Home/Filings/4/0002020260-24-000002
4//SEC Filing

Nisco James 4

Accession 0002020260-24-000002

CIK 0000320017other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 5:19 PM ET

Size

6.7 KB

Accession

0002020260-24-000002

Insider Transaction Report

Form 4
Period: 2024-10-01
Nisco James
SVP, Fin/Treas, Chief Actg Off
Transactions
  • Tax Payment

    Common Stock

    2024-10-01$2.93/sh1,701$4,98412,956 total
  • Award

    Common Stock

    2024-10-01$2.93/sh+3,300$9,66914,657 total
Footnotes (3)
  • [F1]Reflects 3,300 in performance-based stock units, the criteria for which was satisfied on October 1, 2024 and which vested in full on that same day.
  • [F2]Includes 9,482 unvested restricted stock.
  • [F3]Shares withheld as payment of a tax liability on vesting of performance-based stock units.

Issuer

LISATA THERAPEUTICS, INC.

CIK 0000320017

Entity typeother

Related Parties

1
  • filerCIK 0002020260

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:19 PM ET
Size
6.7 KB